BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 27784544)

  • 1. Erythrocytosis and Polycythemia Secondary to Testosterone Replacement Therapy in the Aging Male.
    Jones SD; Dukovac T; Sangkum P; Yafi FA; Hellstrom WJ
    Sex Med Rev; 2015 Apr; 3(2):101-112. PubMed ID: 27784544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obstructive Sleep Apnea Is Associated With Polycythemia in Hypogonadal Men on Testosterone Replacement Therapy.
    Lundy SD; Parekh NV; Shoskes DA
    J Sex Med; 2020 Jul; 17(7):1297-1303. PubMed ID: 32307242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythrocytosis Following Testosterone Therapy.
    Ohlander SJ; Varghese B; Pastuszak AW
    Sex Med Rev; 2018 Jan; 6(1):77-85. PubMed ID: 28526632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Erythrocytosis During Concomitant Testosterone and SGLT2-Inhibitor Treatment: A Warning From Two Clinical Cases.
    Motta G; Zavattaro M; Romeo F; Lanfranco F; Broglio F
    J Clin Endocrinol Metab; 2019 Mar; 104(3):819-822. PubMed ID: 30395251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone and the Prostate.
    Tan RB; Silberstein JL; Hellstrom WJ
    Sex Med Rev; 2014 Oct; 2(3-4):112-120. PubMed ID: 27784562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemochromatosis Gene Mutation in Persons Developing Erythrocytosis on Combined Testosterone and SGLT-2 Inhibitor Therapy.
    Schumacher KA; Gosmanov AR
    J Investig Med High Impact Case Rep; 2022; 10():23247096221111774. PubMed ID: 35848311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased risk of erythrocytosis in men with type 2 diabetes treated with combined sodium-glucose cotransporter-2 inhibitor and testosterone replacement therapy.
    Gosmanov AR; Gemoets DE; Schumacher KA
    J Endocrinol Invest; 2024 Mar; ():. PubMed ID: 38536657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence and demographic determinants of blood donors receiving testosterone replacement therapy at a large USA blood service organization.
    Hazegh K; Bravo MD; Kamel H; Dumont L; Kanias T
    Transfusion; 2020 May; 60(5):947-954. PubMed ID: 32176332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial.
    Marks LS; Mazer NA; Mostaghel E; Hess DL; Dorey FJ; Epstein JI; Veltri RW; Makarov DV; Partin AW; Bostwick DG; Macairan ML; Nelson PS
    JAMA; 2006 Nov; 296(19):2351-61. PubMed ID: 17105798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cross-sectional comparison of secondary polycythemia in testosterone-deficient men treated with nasal testosterone gel vs. intramuscular testosterone cypionate.
    Best JC; Gonzalez D; Masterson TA; Blachman-Braun R; Pai R; Ramasamy R
    Can Urol Assoc J; 2021 Feb; 15(2):E118-E122. PubMed ID: 32744998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated Dihydrotestosterone is Associated with Testosterone Induced Erythrocytosis.
    Aghazadeh M; Pastuszak AW; Johnson WG; McIntyre MG; Hsieh TM; Lipshultz LI
    J Urol; 2015 Jul; 194(1):160-5. PubMed ID: 25596360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of subcutaneous testosterone pellet therapy with developing secondary polycythemia.
    Rotker KL; Alavian M; Nelson B; Baird GL; Miner MM; Sigman M; Hwang K
    Asian J Androl; 2018; 20(2):195-199. PubMed ID: 29205178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late-life onset hypogonadism: a review.
    Bassil N; Morley JE
    Clin Geriatr Med; 2010 May; 26(2):197-222. PubMed ID: 20497841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone Replacement Therapy and Components of the Metabolic Syndrome.
    Anaissie J; Roberts NH; Wang P; Yafi FA
    Sex Med Rev; 2017 Apr; 5(2):200-210. PubMed ID: 28202344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of health risks of low testosterone and testosterone administration.
    Jia H; Sullivan CT; McCoy SC; Yarrow JF; Morrow M; Borst SE
    World J Clin Cases; 2015 Apr; 3(4):338-44. PubMed ID: 25879005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone Replacement Therapy and Mortality in Older Men.
    Hackett GI
    Drug Saf; 2016 Feb; 39(2):117-30. PubMed ID: 26482385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone replacement therapy.
    Barbonetti A; D'Andrea S; Francavilla S
    Andrology; 2020 Nov; 8(6):1551-1566. PubMed ID: 32068334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood donation and testosterone replacement therapy.
    Chin-Yee B; Lazo-Langner A; Butler-Foster T; Hsia C; Chin-Yee I
    Transfusion; 2017 Mar; 57(3):578-581. PubMed ID: 28150363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update in testosterone therapy for men.
    Corona G; Rastrelli G; Forti G; Maggi M
    J Sex Med; 2011 Mar; 8(3):639-54; quiz 655. PubMed ID: 21711483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone therapy of men with type 2 diabetes mellitus - a randomized, double-blinded, placebo-controlled study.
    Magnussen LV
    Dan Med J; 2017 Jul; 64(7):. PubMed ID: 28673384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.